FEBS Letters
Volume 580, Issue 4 , Pages 1056-1063, 13 February 2006

The translocation mechanism of P-glycoprotein

Edited by Gerrit van Meer

  • Richard Callaghan

      Affiliations

    • Nuffield Department of Clinical Laboratory Sciences, Level 4, John Radcliffe Hospital, University of Oxford, Oxford, OX3 9DU, United Kingdom
    • Corresponding Author InformationCorresponding author. Fax: +44 1865 221 834.
  • ,
  • Robert C. Ford

      Affiliations

    • Faculty of Life Sciences, Jackson’s Mill, University of Manchester, P.O. Box 88, Sackville Street, Manchester, M60 1QD, United Kingdom
  • ,
  • Ian D. Kerr

      Affiliations

    • Centre for Biochemistry and Cell Biology, School of Biomedical Sciences, University of Nottingham, Queen’s Medical Centre, Nottingham NG7 2UH, United Kingdom

Received 17 October 2005; received in revised form 16 November 2005; accepted 16 November 2005. published online 14 December 2005.

Abstract 

Multidrug transporters are involved in mediating the failure of chemotherapy in treating several serious diseases. The archetypal multidrug transporter P-glycoprotein (P-gp) confers resistance to a large number of chemically and functionally unrelated anti-cancer drugs by mediating efflux from cancer cells. The ability to efflux such a large number of drugs remains a biological enigma and the lack of mechanistic understanding of the translocation pathway used by P-gp prevents rational design of compounds to inhibit its function. The translocation pathway is critically dependent on ATP hydrolysis and drug interaction with P-gp is possible at one of a multitude of allosterically linked binding sites. However, aspects such as coupling stoichiometry, molecular properties of binding sites and the nature of conformational changes remain unresolved or the centre of considerable controversy. The present review attempts to utilise the available data to generate a detailed sequence of events in the translocation pathway for this dexterous protein.

Keywords: P-glycoprotein, Membrane transport, Drug-protein interaction, Drug-binding

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0014-5793(05)01476-6

doi:10.1016/j.febslet.2005.11.083

FEBS Letters
Volume 580, Issue 4 , Pages 1056-1063, 13 February 2006